FITC Labeled Human Fibrinogen


SKU: FIB-FITC Categories: ,

Product Description

FITC Labeled Human Fibrinogen

Human fibrinogen amino terminal labeled with fluorescein isothiocyanate (FITC). Prepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw in a 37°C water bath without agitation until completely liquid, then gently mix before use. Keep fibrinogen at 25-37°C, aliquot and flash freeze unused portion.

Gene ID: 2243, 2244, 2266

Swiss-Prot/UniProt ID: P02671, P02675, P02679

View sample datasheet

View sample certificate of analysis

View material safety data sheet

Ask a question about this product

Additional Information



Molecular Weight

Extinction Coefficient



Shipping Conditions




Sample Size

Sample Concentration

Sample Volume

Gene Name

Gene ID

UniProt ID

1. O’brien XM, Heflin KE, Lavigne LM et-al. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem. 2012;287 (5): 3337-48. doi:10.1074/jbc.M111.298307Free text at pubmedPubmed citation

2. Auxier JA, Dill JK, Schilke KF et-al. Blood protein repulsion after peptide entrapment in pendant PEO layers. Biotechnol. Appl. Biochem. 2014;doi:10.1002/bab.1201Pubmed citation

3. Florova G, Azghani A, Karandashova S, et al. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol. 2015;52(4):429-37. link to article

4. Komissarov AA, Florova G, Azghani AO, et al. The time course of resolution of adhesions during fibrinolyitic therapy in tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol. 2015;:ajplung.00136.2015. link to article

5. Singh S, Houng A, Reed GL. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation. Circulation. 2017;135(11):1011-1020. Link to article